Eli Lilly and Company

Consultor(a) Técnico(a) Imunologia Senior - Belo Horizonte/MG

Brazil

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

Candidates should possess a relevant higher education degree, such as a degree in Pharmacy, Biology, or a related field, and demonstrate a strong understanding of immunology and immunobiological medications. Prior experience as a Technical Consultant in the immunology market and with high-cost medications is preferred. Fluency in English is required, with intermediate proficiency being desirable. Residing in Belo Horizonte/MG and having approximately 70% travel availability are essential prerequisites.

Responsibilities

The Senior Technical Consultant will provide technical consulting, commercial support, and market access strategies for immunology medications, specifically targeting dermatological conditions like atopic dermatitis, psoriasis, and psoriatic arthritis. This role involves conducting medical visits, negotiating commercial deals, advising on private and public access to high-cost medications, integrating with various internal teams (Medical, Marketing, Access, MCE, Commercial), and implementing marketing strategies to maximize product demand and improve patient quality of life. The consultant will also analyze the strategic market dynamics, including the private and public healthcare systems, and develop strategic action plans using SWOT analysis and other relevant tools.

Skills

Medical visits
Negotiation
Market access
Multichannel engagement
Virtual and in-person communication
Sales techniques
Account management
Strategic analysis
SWOT analysis
Implementation and measurement of action plans
Knowledge of high-cost pharmaceutical market

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI